Albemarle (ALB) Registers a Bigger Fall Than the Market: Important Facts to Note

Albemarle (ALB) declined 1.71% to $105.78, underperforming the S&P 500's 0.25% loss. The specialty chemicals company has fallen 20.6% over the past month, significantly worse than its sector's 8.47% decline. Despite strong earnings forecasts showing 1442% EPS growth and 16% revenue growth for the upcoming quarter, ALB holds a Zacks Rank #4 (Sell) rating. The stock trades at a Forward P/E of 9.45, below its industry average of 15.9, with a PEG ratio of 0.63 suggesting undervaluation.